J
Jessica K De Freitas
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 33
Citations - 1899
Jessica K De Freitas is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Deep learning & Coronary artery disease. The author has an hindex of 13, co-authored 31 publications receiving 980 citations. Previous affiliations of Jessica K De Freitas include Mount Sinai Hospital & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection.
Anuradha Lala,Anuradha Lala,Kipp W. Johnson,James L. Januzzi,Adam Russak,Ishan Paranjpe,Felix Richter,Shan Zhao,Sulaiman Somani,Tielman Van Vleck,Akhil Vaid,Fayzan Chaudhry,Jessica K De Freitas,Zahi A. Fayad,Sean Pinney,Matthew A. Levin,Alexander W. Charney,Emilia Bagiella,Jagat Narula,Benjamin S. Glicksberg,Girish N. Nadkarni,Donna M. Mancini,Valentin Fuster +22 more
TL;DR: Cardiovascular disease (CVD) including coronary artery disease, atrial fibrillation, and heart failure, was more prevalent in patients with higher troponin concentrations, as were hypertension and diabetes.
Journal ArticleDOI
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection.
Vijendra Ramlall,Phyllis M. Thangaraj,Cem Meydan,Cem Meydan,Jonathan Foox,Daniel Butler,Jacob Kim,Ben May,Jessica K De Freitas,Benjamin S. Glicksberg,Christopher E. Mason,Nicholas P. Tatonetti,Sagi Shapira +12 more
TL;DR: A combination of clinical and molecular analyses supports an association between disorders of immune complement or coagulation with poor outcome in patients with SARS-CoV-2 infection.
Journal ArticleDOI
Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City
Keith Sigel,Talia H. Swartz,Eddye Golden,Ishan Paranjpe,Sulaiman Somani,Felix Richter,Jessica K De Freitas,Riccardo Miotto,Shan Zhao,Paz Polak,Tinaye Mutetwa,Stephanie Factor,Saurabh Mehandru,Michael P. Mullen,Francesca Cossarini,Erwin P. Bottinger,Erwin P. Bottinger,Zahi A. Fayad,Miriam Merad,Sacha Gnjatic,Judith A. Aberg,Alexander W. Charney,Girish N. Nadkarni,Benjamin S. Glicksberg +23 more
TL;DR: No differences in adverse outcomes associated with HIV infection for hospitalized COVID-19 patients compared to a demographically similar patient group.
Journal ArticleDOI
Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients With COVID-19 in New York City: Model Development and Validation.
Akhil Vaid,Sulaiman Somani,Adam Russak,Jessica K De Freitas,Fayzan Chaudhry,Ishan Paranjpe,Kipp W. Johnson,Samuel J. Lee,Riccardo Miotto,Felix Richter,Shan Zhao,Noam D. Beckmann,Nidhi Naik,Arash Kia,Prem Timsina,Anuradha Lala,Manish Paranjpe,Eddye Golden,Matteo Danieletto,Manbir Singh,Dara Meyer,Paul F. O'Reilly,Laura M. Huckins,Patricia Kovatch,Joseph Finkelstein,Robert Freeman,Edgar Argulian,Andrew Kasarskis,Bethany Percha,Judith A. Aberg,Emilia Bagiella,Carol R. Horowitz,Barbara Murphy,Eric J. Nestler,Eric E. Schadt,Judy H. Cho,Carlos Cordon-Cardo,Valentin Fuster,Dennis S. Charney,David Reich,Erwin P. Bottinger,Erwin P. Bottinger,Matthew A. Levin,Jagat Narula,Zahi A. Fayad,Allan C. Just,Alexander W. Charney,Girish N. Nadkarni,Benjamin S. Glicksberg +48 more
TL;DR: Externally and prospectively trained and validated machine learning models for mortality and critical events for patients with COVID-19 at different time horizons were developed and established model interpretability to identify and rank variables that drive model predictions.
Posted ContentDOI
Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection
Anuradha Lala,Kipp W. Johnson,Adam Russak,Ishan Paranjpe,Shan Zhao,Sulaiman Solani,Akhil Vaid,Fayzan Chaudhry,Jessica K De Freitas,Zahi A. Fayad,Sean Pinney,Matthew A. Levin,Alexander W. Charney,Emilia Bagiella,Jagat Narula,Benjamin S. Glicksberg,Girish N. Nadkarni,James L. Januzzi,Donna M. Mancini,Valentin Fuster +19 more
TL;DR: Myocardial injury, manifesting as troponin elevation appears to be common among patients hospitalized with COVID-19 but present at generally low levels, and likely represents non-ischemic or secondary myocardial Injury.